Aurobindo Pharma Share Price
- All
- News
-
Aurobindo Pharma Edges Lower After Posting Rs 801 Crore Profit In March Quarter
Aurobindo Pharma Share Price: On Tuesday, Aurobindo Pharma opened on the BSEat Rs 1,000,inching to an intra day high of Rs 1,007.95, and an intra day low of Rs 959.90, so far.
-
Sebi Slaps Rs 23 Crore Penalty On Aurobindo Pharma Promoters; Shares Fall
Aurobindo Share Price: Sebi's penalty is for alleged insider trading violations done by Aurobindo Pharma's promoters between 2008 and 2009 when it entered into agreement with Pfizer.
-
Sell Aurobindo Pharma; Buy Aditya Birla Fashion: Choice Broking
Share Market Tips: Choice Broking has recommended selling Aurobindo Pharma in the range of Rs 589.90 and up to Rs 593 for target price of Rs 565 with stop loss at Rs 603.
-
Lawsuit Against Aurobindo Pharma, Other Drug Makers Filed In US
Aurobindo said it does not anticipate that these matters will have a material impact on the its operations or business results.
-
Aurobindo Pharma Shares Extend Gains To Second Day After US Deal
Analysts said the deal was positive for Aurobindo Pharma, which said it would make the company the second largest generic player in the US by number of prescriptions. Aurobindo Pharma shares closed 9 per cent higher on Thursday. On Friday, the shares were set to close higher for a third session in a row. At the day's highest level, the shares have ...
-
Aurobindo Pharma Shares Jump 6% After Drug Maker Announces $900-Million US Acquisition
Aurobindo Pharma share price jumped more than 6 per cent in intraday trade with large volumes after the announcement. Aurobindo Pharma said it will acquire the dermatology and oral solids businesses from Sandoz Inc, USA, a unit of Swiss pharmaceutical company Novartis. Aurobindo Pharma said the deal worth $900 million was expected to close in 2019...
-
Aurobindo Pharma Shares Gains 11%, Credit Suisse Maintains Outperform
Traders say that surge in today's stock price of Aurobindo Pharma is a combination of back of short-covering and Credit Suisse maintaining its outperform call on the stock.
-
Aurobindo Pharma Shares Hit 9-Month Low On US Price Fixing Lawsuit
The lawsuit, filed in the US District Court for the District of Connecticut by 20 US states, also named Heritage Pharmaceuticals Inc, a company owned by Emcure Pharma Ltd, as a "ring leader" of the price manipulation.
-
Founders Of Aurobindo Pharma To Sell Up To $135-Million Shares
The price range equates to a discount of between 3.1 per cent and 5.5 per cent of Wednesday closing price of Rs 856.85 ($12.83).
-
Aurobindo Pharma Surges Over 4%, Hits 52-Week High
Including today's gain the stock has surged around 14 per cent in last seven trading sessions after the company said that it had received final approval from the US Food & Drug Administration (US FDA) to manufacture and market extended Phenytoin sodium capsules, which is an anti-epileptic drug used for controlling seizures.
-
Aurobindo Pharma allots equity shares
Ajay Singh, director of SpiceJet, says a 10 per cent service tax imposed on domestic air travel in the Budget would mean an increase in air ticket prices by about Rs 350-400 given that the average economy fair is between Rs 3500-4000.
-
Aurobindo Pharma Edges Lower After Posting Rs 801 Crore Profit In March Quarter
Aurobindo Pharma Share Price: On Tuesday, Aurobindo Pharma opened on the BSEat Rs 1,000,inching to an intra day high of Rs 1,007.95, and an intra day low of Rs 959.90, so far.
-
Sebi Slaps Rs 23 Crore Penalty On Aurobindo Pharma Promoters; Shares Fall
Aurobindo Share Price: Sebi's penalty is for alleged insider trading violations done by Aurobindo Pharma's promoters between 2008 and 2009 when it entered into agreement with Pfizer.
-
Sell Aurobindo Pharma; Buy Aditya Birla Fashion: Choice Broking
Share Market Tips: Choice Broking has recommended selling Aurobindo Pharma in the range of Rs 589.90 and up to Rs 593 for target price of Rs 565 with stop loss at Rs 603.
-
Lawsuit Against Aurobindo Pharma, Other Drug Makers Filed In US
Aurobindo said it does not anticipate that these matters will have a material impact on the its operations or business results.
-
Aurobindo Pharma Shares Extend Gains To Second Day After US Deal
Analysts said the deal was positive for Aurobindo Pharma, which said it would make the company the second largest generic player in the US by number of prescriptions. Aurobindo Pharma shares closed 9 per cent higher on Thursday. On Friday, the shares were set to close higher for a third session in a row. At the day's highest level, the shares have ...
-
Aurobindo Pharma Shares Jump 6% After Drug Maker Announces $900-Million US Acquisition
Aurobindo Pharma share price jumped more than 6 per cent in intraday trade with large volumes after the announcement. Aurobindo Pharma said it will acquire the dermatology and oral solids businesses from Sandoz Inc, USA, a unit of Swiss pharmaceutical company Novartis. Aurobindo Pharma said the deal worth $900 million was expected to close in 2019...
-
Aurobindo Pharma Shares Gains 11%, Credit Suisse Maintains Outperform
Traders say that surge in today's stock price of Aurobindo Pharma is a combination of back of short-covering and Credit Suisse maintaining its outperform call on the stock.
-
Aurobindo Pharma Shares Hit 9-Month Low On US Price Fixing Lawsuit
The lawsuit, filed in the US District Court for the District of Connecticut by 20 US states, also named Heritage Pharmaceuticals Inc, a company owned by Emcure Pharma Ltd, as a "ring leader" of the price manipulation.
-
Founders Of Aurobindo Pharma To Sell Up To $135-Million Shares
The price range equates to a discount of between 3.1 per cent and 5.5 per cent of Wednesday closing price of Rs 856.85 ($12.83).
-
Aurobindo Pharma Surges Over 4%, Hits 52-Week High
Including today's gain the stock has surged around 14 per cent in last seven trading sessions after the company said that it had received final approval from the US Food & Drug Administration (US FDA) to manufacture and market extended Phenytoin sodium capsules, which is an anti-epileptic drug used for controlling seizures.
-
Aurobindo Pharma allots equity shares
Ajay Singh, director of SpiceJet, says a 10 per cent service tax imposed on domestic air travel in the Budget would mean an increase in air ticket prices by about Rs 350-400 given that the average economy fair is between Rs 3500-4000.
